PetVivo Holdings Inc. (PETV): Price and Financial Metrics
PETV Price/Volume Stats
Current price | $1.08 | 52-week high | $2.95 |
Prev. close | $1.07 | 52-week low | $0.55 |
Day low | $1.04 | Volume | 22,504 |
Day high | $1.10 | Avg. volume | 36,601 |
50-day MA | $1.16 | Dividend yield | N/A |
200-day MA | $1.52 | Market Cap | 18.11M |
PETV Stock Price Chart Interactive Chart >
PETV Stock Summary
- PETV's price/sales ratio is 16.27; that's higher than the P/S ratio of 93.17% of US stocks.
- With a year-over-year growth in debt of 347.26%, PETVIVO HOLDINGS INC's debt growth rate surpasses 97.34% of about US stocks.
- As for revenue growth, note that PETV's revenue has grown 147.54% over the past 12 months; that beats the revenue growth of 96.6% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to PETVIVO HOLDINGS INC, a group of peers worth examining would be OFIX, CETX, SWBI, UGRO, and DGLY.
- Visit PETV's SEC page to see the company's official filings. To visit the company's web site, go to www.petvivo.com.
PETV Valuation Summary
- PETV's price/sales ratio is 15.9; this is 622.73% higher than that of the median Healthcare stock.
- PETV's price/sales ratio has moved NA NA over the prior 113 months.
Below are key valuation metrics over time for PETV.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
PETV | 2023-12-29 | 15.9 | 15.5 | -1.4 | -1.5 |
PETV | 2023-12-28 | 15.8 | 15.4 | -1.4 | -1.5 |
PETV | 2023-12-27 | 15.4 | 15.0 | -1.3 | -1.4 |
PETV | 2023-12-26 | 16.1 | 15.7 | -1.4 | -1.5 |
PETV | 2023-12-22 | 17.3 | 16.8 | -1.5 | -1.6 |
PETV | 2023-12-21 | 17.5 | 17.0 | -1.5 | -1.6 |
PETV Growth Metrics
- The 4 year net income to common stockholders growth rate now stands at 86.59%.
- The year over year revenue growth rate now stands at 818.95%.
- Its 2 year cash and equivalents growth rate is now at 57609.57%.
The table below shows PETV's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 0.847023 | -6.869724 | -8.165398 |
2022-09-30 | 0.387918 | -6.584401 | -7.495909 |
2022-06-30 | 0.169615 | -5.620795 | -6.489794 |
2022-03-31 | 0.115586 | -4.174957 | -5.014995 |
2021-12-31 | 0.065401 | -3.075964 | -3.561249 |
2021-09-30 | 0.014904 | -1.915159 | -2.956873 |
PetVivo Holdings Inc. (PETV) Company Bio
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.
Latest PETV News From Around the Web
Below are the latest news stories about PETVIVO HOLDINGS INC that investors may wish to consider to help them evaluate PETV as an investment opportunity.
New to The Street Announces its Five Corporate Guest Appearances, Show Airs as Sponsored Programming on Bloomberg TV and the FOX Business Network; Broadcastings Begin on Saturday, December 23, 2023, at 6:30 PM ETThe Shows Features its Newest Business Segment, "Money Makers," with TV Host Colin Jordon New to The Street Announces its Five Corporate Guests Appearances, Show Airs as Sponsored Programming on Bloomberg TV and the FOX Business Network; Broadcastings Begin on Saturday, December 23, 2023, at 6:30 PM ET Featuring: 1). EquitySet, LLC (equityset.com) 2). Drinique 3). Hempacco Co., Inc. (NASDAQ: HPCO) ($HPCO) 4). REA (RealEstateAccounting.co) 5). Sekur Private Data, Ltd. (OTCQB: SWISF) (CSE: SKUR) ( |
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH COVETRUS NORTH AMERICA, LLCMINNEAPOLIS, Dec. 22, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Covetrus North America, LLC (“Covetrus”). Covetrus will inventory, market and promote PetVivo’s veterinary medical device, Spryng™ with OsteoCushion™ technolog |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start off Thursday with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! |
PetVivo Holdings, Inc. Achieves Distribution Milestone Surpassing 4500 Syringes of Spryng™ in 2023MINNEAPOLIS, MN, US, Dec. 21, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company"), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, achieved a significant milestone – surpassing 4500 syringes of Spryng™ with OsteoCushion™ technology distributed to veterinarians in the 2023 calendar year. Thanks to the support of veterinarians throughout the United States, Spryng has expe |
New to The Street Re-signs PetVivo Holdings, Inc. for another 12-Month TV Media Series; Agreement Includes Commercials and Billboard AdsNew to The Street Re-signs PetVivo Holdings, Inc. for another 12-Month TV Media Series; Agreement Includes Commercials and Billboard Ads New to The Street, announces re-signing PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) to a new 12-month media series contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and commercials and streaming digital billboard aids throughout key locations in New York City - https://petvivo.com/ & https://www.newtoth |
PETV Price Returns
1-mo | -8.47% |
3-mo | 1.89% |
6-mo | -41.30% |
1-year | -61.70% |
3-year | -89.74% |
5-year | -19.00% |
YTD | 1.89% |
2023 | -45.92% |
2022 | -48.01% |
2021 | -71.55% |
2020 | 578.79% |
2019 | N/A |
Loading social stream, please wait...